Contraceptie als methode in het beheer van hoefdierpopulaties [PDF]
, 2003 Bezorgdheid over dierenwelzijn en praktische problemen met lethale methoden hebben geleid tot de ontwikkeling van contraceptiemiddelen om hoefdierpopulaties te beheren.
Kuiper, M.W., Wieren, S.E., van
core +7 more sources
Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care [PDF]
, 2017 Background:Androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone (LHRH) agonists is well established for the treatment of men with metastatic prostate cancer.
Janknegt, Robert +5 more
core +1 more source
Novasure as a mechanical endometrial preparation agent in large uteri. [PDF]
, 2012 OBJECTIVE: We evaluated Novasure ablation as a mechanical endometrial preparation agent before Roller Ball endometrial ablation in lieu of GnRH agonists in large uteri.
Chatwani, Ashwin J +4 more
core +1 more source
Tolerability and Shared Decision-Making in the Hormonal Management of Endometriosis-Associated Pain
BiomedicinesBackground: The management of endometriosis-associated pain has traditionally focused on analgesic efficacy. However, with high-level evidence demonstrating therapeutic equivalence among principal hormonal classes, the paradigm has shifted towards a ...
Diogo Pinto da Costa Viana +6 more
doaj +1 more source
Treatment of overweight and obese girls experiencing central precocious puberty: a comparison of the effectiveness of leuprolide acetate and triptorelin pamoate [PDF]
Annals of Pediatric Endocrinology & MetabolismPurpose Gonadotropin-releasing hormone agonists are the standard treatment for central precocious puberty (CPP). These agonists include leuprolide acetate and triptorelin pamoate, but research data for the relative effectiveness of these 2 treatments in ...
Thanaporn Thaneetrakool +6 more
doaj +1 more source
JCRPE, 2020 Objective:Doses of gonadotropin releasing hormone (GnRH) analogues used to treat idiopathic central precocious puberty (iCPP) vary among clinicians. Study aims were to evaluate the efficacy of a monthly 3.75 mg dose of leuprolide acetate (LA) to suppress
Doğuş Vurallı +6 more
doaj +1 more source
Health considerations for transgender women and remaining unknowns : a narrative review [PDF]
, 2019 Transgender (trans) women (TW) were assigned male at birth but have a female gender identity or gender expression. The literature on management and health outcomes of TW has grown recently with more publication of research.
Defreyne, Justine +6 more
core +1 more source
Biology of Sex Differences, 2023 Highlights Leuprolide acetate (50 µg/kg, postnatal day 25–50) suppresses pubertal development in female and male rats. Estrous cyclicity is suppressed during treatment in female rats.
Fay A. Guarraci +11 more
doaj +1 more source
Efficacy of Leuprorelide acetate (Eligard®) in daily practice in Brazil: a retrospective study with depot formulations in patients with prostate cancer [PDF]
International Brazilian Journal of Urology, 2020 Introduction: Androgen deprivation therapy (ADT) is the mainstay of therapy for advanced prostate cancer. Studies addressing the efficacy of different depot formulations of long acting luteinizing hormone releasing hormone agonists in the Brazilian ...
Carla S. M. de Freitas, Aleida N. Soares
doaj +1 more source
Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome [PDF]
, 1996 BACKGROUND Insulin resistance and increased ovarian cytochrome P450c17α activity are both features of the polycystic ovary syndrome. P450c17α, which is involved in androgen biosynthesis, has both 17α-hydroxylase and 17,20-lyase activities.
Jakubowicz, Daniela J., , M.D. +1 more
core +2 more sources